Post
📉 Tech Stocks vs Defensive Stocks: Which Is Better During a Market Crash?

A market crash is one of the biggest tests of an investor's strategy. When stock prices start falling, confidence weakens, volatility increases, and even fundamentally strong companies can experience significant selling pressure.

Imagine waking up to see the Nasdaq down 2.5% and the S&P 500 falling 1.9%. Suddenly, investors face an important decision: Should they look for discounted technology stocks, or should they move toward defensive companies that may offer greater stability?

Personally, I believe the answer depends on the investment horizon, risk tolerance, and the quality of the businesses being considered. However, during periods of uncertainty, I would give serious attention to defensive healthcare stocks, particularly
Johnson & Johnson ( $JNJ )

💻 Technology Stocks: Opportunity Comes With Risk

Technology companies have enormous long-term growth potential. Artificial intelligence, cloud computing, semiconductors, cybersecurity, and digital infrastructure continue to create opportunities for businesses and investors.

During a market correction, some technology stocks may become available at significantly lower valuations. For long-term investors, this can create an opportunity to invest in fundamentally strong companies at more attractive prices.

However, there is another side to the story.

Technology stocks can be particularly sensitive to changes in interest rates, investor sentiment, earnings expectations, and future growth projections. When market confidence disappears, high-valuation technology companies can experience sharp declines.

A falling stock price does not automatically mean a company has become undervalued. Investors must examine earnings, cash flow, debt, competitive advantages, and future business prospects before making a decision.

*L🏥 Defensive Stocks: Why Healthcare Deserves Attention

This is where the healthcare sector becomes interesting.

Healthcare products and services are essential parts of everyday life. Even when economic conditions become difficult, people continue to need medicines, medical devices, and healthcare services.

That does not make healthcare stocks immune to market crashes, but demand for healthcare is generally less dependent on consumer confidence than demand for many discretionary products.

My defensive stock to watch is Johnson & Johnson ( $JNJ ).

💡 Why I Am Watching Johnson & Johnson

1️⃣ Essential Healthcare Demand

Healthcare demand does not disappear simply because financial markets are declining. This gives companies with established healthcare businesses a potentially more resilient foundation.

2️⃣ Diversified Healthcare Operations

Johnson & Johnson operates across Innovative Medicine and MedTech. Its exposure to different healthcare markets provides investors with a broader business profile rather than dependence on a single technology trend.

3️⃣ Long-Term Business Fundamentals

During a market correction, I believe investors should look beyond daily price movements and focus on business fundamentals. Revenue growth, profitability, product innovation, and financial strength are important factors when evaluating JNJ.

4️⃣ Potential Defensive Exposure

JNJ may deserve a place on the watchlist of investors looking for exposure to the healthcare sector during uncertain market conditions. However, defensive does not mean risk-free. Pharmaceutical competition, patent expirations, regulatory decisions, litigation, and valuation can all affect its performance.

⚖️ So, Tech Stocks or Defensive Stocks?

I would not completely abandon technology stocks during a market crash. Some of the strongest long-term investment opportunities can emerge when temporary market fear pushes quality businesses below their underlying value.

At the same time, concentrating an entire portfolio in high-growth technology companies can increase risk during periods of market stress.

My approach would be to evaluate both categories carefully:

Technology stocks for long-term innovation and potential capital appreciation.
Defensive healthcare stocks for relatively resilient business exposure.
Strong balance sheets and reasonable valuations as important selection criteria.
Diversification to avoid depending too heavily on one sector.

🎯 My Pick: Johnson & Johnson ( $JNJ )

If I had to highlight one defensive healthcare stock during a period of market uncertainty, Johnson & Johnson would be on my list.

I am not suggesting that JNJ will rise every time the Nasdaq falls, or that it cannot experience a significant correction. No stock offers that guarantee.

My point is that investors should not focus exclusively on finding the biggest losers after a market crash. Sometimes, understanding which businesses can maintain demand, generate sustainable earnings, and navigate difficult economic conditions is equally important.

🔥 Final Thought

A market crash changes prices, but it does not necessarily change the long-term value of every business.

The smartest investment decision is not always choosing between growth and safety. It is understanding the risks, comparing valuations, and building a portfolio that can withstand different market environments.

Now I want to know your opinion:

If the Nasdaq falls 2.5% and the S&P 500 drops 1.9%, where would you put your money?

💻 Discounted technology stocks with higher growth potential?

🏥 Defensive healthcare stocks like Johnson & Johnson ( $JNJ )?

Or would you prefer a balanced combination of both?

Let's discuss! 👇

#GateStockTalkSeason #StockMarket #JNJ
#GateStockTalkSeason
$JNJ
jnj
JNJUSDT
Perp
--
+0.19%
post-image
This page contains third-party content and does not constitute any advice, nor does it represent Gate's endorsement of such views. For details, please see disclaimer.
JNJJNJ+0.19%


Add a comment
Add a comment

Comment 6
moathalmahdi
Do your own research (DYOR) 🤓
moathalmahdi
Hold on tight 💪
moathalmahdi
The bull market is in full swing 🐂
miss_1903
Keep us posted 🍿
miss_1903
Solid breakdown 💡
Ghost_Trader
and even fundamentally strong companies can experience significant selling pressure.